Instituto Rosenbusch SA Ordinary Shares - Class B ROSE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ARS 148.00
- Day Range
- ARS 156.00–156.00
- 52-Week Range
- ARS 117.00–300.00
- Bid/Ask
- ARS 137.00 / ARS 0.00
- Shares Outstanding
- 42.59M
- Market Cap
- ARS 6.64B
- Volume/Avg
- 200 / 1,048
Key Statistics
- Price/Earnings (Normalized)
- 0.73
- Price/Sales
- 0.81
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 75
- Website
- https://www.rosenbusch.com
Valuation
|
Metric
|
ROSE
|
|---|---|
Price/Earnings (Normalized) | 0.73 |
Price/Book Value | 0.81 |
Price/Sales | 0.81 |
Price/Cash Flow | — |
Price/Earnings
ROSE
Financial Strength
|
Metric
|
ROSE
|
|---|---|
Quick Ratio | 0.89 |
Current Ratio | 1.79 |
Interest Coverage | −0.38 |
Quick Ratio
ROSE
Profitability
|
Metric
|
ROSE
|
|---|---|
Return on Assets (Normalized) | 3.29% |
Return on Equity (Normalized) | 30.58% |
Return on Invested Capital (Normalized) | 43.21% |
Return on Assets
ROSE
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|r$Tz#V^T | LOCK|v$JHy | $68B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|gXwQW#>% | LOCK|!vGHP | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|RlBqsZP | LOCK|^<! | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|$?#Lj># | LOCK|#?< | $31B | |||
| Viatris Inc
VTRS
| LOCK|kb$^d% | LOCK|V^L | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|D&% | LOCK|p&x | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Z&BMJV | LOCK|R^% | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|N<?<z$ | LOCK|@< | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|vWkSS<Y | LOCK|f@<$M | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|F>T>x&j | LOCK|FRM | $2B |
United States